[Prolongation of oral anticoagulant treatment for eighteen months versus placebo at the decline of a first episode of idiopathic pulmonary embolism treated for six months: a randomized, multicentric, double blind trial. 2006 National PHRC (Hospital clinical research programme): "PADIS-EP/Prolongation of anticoagulant treatment for 18 months for a first episode of PE initially treated for 6 months"]. - Université de Bretagne Occidentale
Journal Articles Revue de Pneumologie Clinique Year : 2008

[Prolongation of oral anticoagulant treatment for eighteen months versus placebo at the decline of a first episode of idiopathic pulmonary embolism treated for six months: a randomized, multicentric, double blind trial. 2006 National PHRC (Hospital clinical research programme): "PADIS-EP/Prolongation of anticoagulant treatment for 18 months for a first episode of PE initially treated for 6 months"].

Domains

Human health and pathology

Ghislaine Calvez  : Connect in order to contact the contributor

https://hal.univ-brest.fr/hal-00685681

Submitted on : Thursday, April 5, 2012-4:09:39 PM

Last modification on : Thursday, October 31, 2024-3:22:24 PM

No file

Dates and versions

hal-00685681 , version 1 (05-04-2012)

Identifiers

Cite

Francis Couturaud. [Prolongation of oral anticoagulant treatment for eighteen months versus placebo at the decline of a first episode of idiopathic pulmonary embolism treated for six months: a randomized, multicentric, double blind trial. 2006 National PHRC (Hospital clinical research programme): "PADIS-EP/Prolongation of anticoagulant treatment for 18 months for a first episode of PE initially treated for 6 months"].. Revue de Pneumologie Clinique, 2008, 64 (6), pp.332-6. ⟨10.1016/j.pneumo.2008.09.012⟩. ⟨hal-00685681⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-BREST GETBO IBSAM
20 View
0 Download

Altmetric

Share

More